Boston Scientific Corporation vs Takeda Pharmaceutical Company Limited
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก ๋น๊ต
Boston Scientific Corporation
$66.2B
์์ #229
Takeda Pharmaceutical Company Limited
$68.4B
์์ #226
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก
์ฃผ์ ์๊ฐ
- Boston Scientific Corporation์ด(๊ฐ) 2002๋ ๊น์ง Takeda Pharmaceutical Company Limited์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Takeda Pharmaceutical Company Limited์ด(๊ฐ) 2006๋ ๊น์ง Boston Scientific Corporation์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Boston Scientific Corporation์ด(๊ฐ) 2018๋ ๊น์ง Takeda Pharmaceutical Company Limited์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Takeda Pharmaceutical Company Limited์ด(๊ฐ) 2026๋ ๊น์ง Boston Scientific Corporation์(๋ฅผ) ์ถ์ํ์ต๋๋ค
์ฐ๋๋ณ ๋น๊ต
| ์ฐ๋ | Boston Scientific Corporation | Takeda Pharmaceutical Company Limited | ์ ๋ |
|---|---|---|---|
| 2026 | $66.2B | $68.4B | Takeda Pharmaceutical Company Limited |
| 2025 | $141.7B | $50.3B | Boston Scientific Corporation |
| 2024 | $132.8B | $41.6B | Boston Scientific Corporation |
| 2023 | $85.9B | $38.6B | Boston Scientific Corporation |
| 2022 | $68.8B | $37.6B | Boston Scientific Corporation |
| 2021 | $63.1B | $27.3B | Boston Scientific Corporation |
| 2020 | $53.4B | $31.2B | Boston Scientific Corporation |
| 2019 | $67.2B | $34.2B | Boston Scientific Corporation |
| 2018 | $52.5B | $28.0B | Boston Scientific Corporation |
| 2017 | $36.8B | $46.8B | Takeda Pharmaceutical Company Limited |
| 2016 | $32.1B | $34.2B | Takeda Pharmaceutical Company Limited |
| 2015 | $27.4B | $41.4B | Takeda Pharmaceutical Company Limited |
| 2014 | $19.7B | $33.1B | Takeda Pharmaceutical Company Limited |
| 2013 | $17.9B | $30.8B | Takeda Pharmaceutical Company Limited |
| 2012 | $8.5B | $23.7B | Takeda Pharmaceutical Company Limited |
| 2011 | $7.9B | $19.8B | Takeda Pharmaceutical Company Limited |
| 2010 | $11.3B | $22.3B | Takeda Pharmaceutical Company Limited |
| 2009 | $13.4B | $20.5B | Takeda Pharmaceutical Company Limited |
| 2008 | $11.5B | $23.7B | Takeda Pharmaceutical Company Limited |
| 2007 | $17.3B | $32.5B | Takeda Pharmaceutical Company Limited |
| 2006 | $25.5B | $39.6B | Takeda Pharmaceutical Company Limited |
| 2005 | $36.4B | $30.4B | Boston Scientific Corporation |
| 2004 | $52.8B | $24.2B | Boston Scientific Corporation |
| 2003 | $54.6B | $19.6B | Boston Scientific Corporation |
| 2002 | $31.6B | $22.5B | Boston Scientific Corporation |
| 2001 | $17.9B | $26.6B | Takeda Pharmaceutical Company Limited |
| 2000 | $10.2B | $30.0B | Takeda Pharmaceutical Company Limited |